Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value:
$16.19M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
HilleVax, Inc.6,724,0006,724,0000$13.92M$9.75M60.21%-$4.17M
Ovid Therapeutics Inc.(OVID)7,531,9967,531,9960$7.01M$2.35M14.51%-$4.66M
Xilio Therapeutics, Inc.(XLO)1,475,1211,475,1210$1.42M$1.07M6.59%-$348.1K
Equillium, Inc.(EQ)1,824,9771,824,9770$1.37M$711.7K4.40%-$657.0K
American Well Corporation(AMWL)77,73377,7330$563.6K$612.5K3.78%+$49.0K
Shattuck Labs, Inc.(STTK)515,619515,6190$623.9K$489.8K3.02%-$134.1K
Lyell Immunopharma, Inc.(LYEL)823,317823,3170$526.9K$442.9K2.74%-$84.0K
Turnstone Biologics895,824895,8240$447.9K$367.3K2.27%-$80.6K
Rani Therapeutics Holdings, Inc.(RANI)203,190203,1900$278.4K$256.0K1.58%-$22.4K
Third Harmonic Bio, Inc.36,83536,8350$379.0K$127.8K0.79%-$251.2K
Standard BioTools Inc.(LAB)16,51516,5150$28.9K$17.8K0.11%-$11.1K
Page 1 of 1
TAKEDA PHARMACEUTICAL CO LTD — 13F Holdings — Q1 2025 | TickerTrail